NOV 24, 2021 4:33 AM PST

Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?

Platinum-based chemotherapies such as oxaliplatin are used to treat gastrointestinal tumors, especially in the advanced setting. Although demonstrated to be an effective treatment, it is one of the most neurotoxic types of chemotherapy. It has been shown that more than 90% of oxaliplatin recipients experience acute neuropathy. This neuropathy, known as chemotherapy-induced peripheral neuropathy (CIPN), can be highly debilitating. Currently, interventions to treat or prevent this condition are limited. The role of cannabis in treating cancer-related pain and certain neuropathic conditions has been studied. However, clinical evidence on the effectiveness of cannabis for treating CIPN is lacking. In February 2021, the results of a retrospective analysis evaluating cannabis for this treatment purpose were published.

In this review, the medical records of 768 patients who had received chemotherapy regimens, including oxaliplatin, were reviewed. Patients were separated into those with no cannabis use, those who used cannabis before oxaliplatin, and those who used cannabis after oxaliplatin. Results demonstrated a protective effect of cannabis that was statistically significant and more robust in those patients who used cannabis before treatment with oxaliplatin. Although this study was retrospective in nature, strengths of this study include data reliability and length of the study period.

The mechanism through which cannabis impacts CIPN is not well understood; however, the results of an animal study published in November 2021 suggest that oxaliplatin-induced neuropathy is modified by cannabis through specific cannabinoid receptors such as CB1. As such, potential therapeutic targets involving the endocannabinoid system are being described. Prospective trials further investigating the use of cannabis in the prevention and treatment of CIPN in humans are on the horizon.

 

Sources: Journal of Clinical Medicine, Therapeutic Advances in Medical Oncology, Neurotoxicity Research

About the Author
  • Dr. Christopher DiMaio is a Science Writer at Labroots. He received his MD from Penn State College of Medicine in 2014. His academic and professional interests include Neuroscience, Behavioral health, Immunology, and Healthcare improvement, among others. He is an active part of his community.
You May Also Like
JUN 11, 2021
Cannabis Sciences
Does Cannabis Interact with the COVID Vaccine?
JUN 11, 2021
Does Cannabis Interact with the COVID Vaccine?
As of June 10th 2021, 43% of people in the US aged 12 and over have been fully vaccinated for COVID-19, with 5 ...
JUN 17, 2021
Health & Medicine
California Workers Can Keep Their Jobs After a Positive Test for THC
JUN 17, 2021
California Workers Can Keep Their Jobs After a Positive Test for THC
Many states in the USA have legalized cannabis for medical and recreational purposes,, But under federal law, it remains ...
SEP 16, 2021
Cannabis Sciences
Cannabis Use and Exercise- A Dire Need for High-quality Evidence
SEP 16, 2021
Cannabis Use and Exercise- A Dire Need for High-quality Evidence
It should come as no surprise that exercise is good for our health. Regular exercise reduces the risks of serious chroni ...
NOV 08, 2021
Plants & Animals
Landmark Study of Hemp Seed Genetics
NOV 08, 2021
Landmark Study of Hemp Seed Genetics
The largest genetic study of cannabis genomes has revealed important considerations for farmers selecting high quality h ...
NOV 10, 2021
Cannabis Sciences
CBD-Hemp Valorization: Essential Oils and Enhanced Cannabinoid Composition as a Sustainable Solution?
NOV 10, 2021
CBD-Hemp Valorization: Essential Oils and Enhanced Cannabinoid Composition as a Sustainable Solution?
Hemp cultivation is propelling to the forefront of the agricultural industry. Harvested primarily for fiber and seeds, i ...
NOV 19, 2021
Neuroscience
Exercise Fights Inflammation by Increasing Body's Own Cannabis Production
NOV 19, 2021
Exercise Fights Inflammation by Increasing Body's Own Cannabis Production
Exercise increases the body’s production of endocannabinoids, which in turn reduces inflammation and pain in condi ...
Loading Comments...